Two genes, FGD5 and ALDH1L1, showed higher frequency and/or extent of downregulation in ccRCC of stage III than in ccRCC of stages I and II (P < 0.06 for FGD5 gene). The gene discussed is FGD5; the disease is nonpapillary renal cell carcinoma.